| |
Content
|
Yu Xiao San 8805 on Type I and Type II Diabetes and
Hypoglycemic Effects of Selected Ingredients
Background
Yu Xiao San 8805, a Traditional Chinese Medicine formulated by
Dr. Lian Jin Chong, is designed to restore pancreatic function and to
proliferate insulin beta cells. Yu Xiao San has been shown to gradually and
effectively lower blood-sugar levels and increase insulin secretion. In addition
it has been shown to regulate carbohydrate metabolism, improve blood
circulation, lower blood cholesterol and increase immune response1. The main
herb components are Gui Jian Yu (Euonymus alatus), Di Gu Pi, (Cortex Lycii
Radicis), Niu Bang Zi (Arctium Lappa L.), Jie Geng (Platycodon Grandiflorum), Li
Zhi He (Litchi Chinensis), Jiang Huang (Curcuma longa), Xi Yang Shen (Panax
quinquefolium L.)
(Note: Yu Xiao
San 8805 is currently sold as a dietary supplement on the market)
Clinical Results:
From Feb. 1992 to Oct. 1992, 10,618 cases were selected as
subjects based
upon the diagnostic criteria established for diabetes mellitus by the World
Health Organization. The patients were drawn for clinical assessment from the
formerly China Beijing Chao Yang District Red Cross Hospital (presently Beijing
Anyuan Hospital) and from 48 comparable hospitals nationwide.
Treatment Criteria and Result
Clinical Recovery: The preferred criterion: FPG (Fasting Plasma Glucose)
<6.1 mmol/L (110 mg/dl), HbA1c <6.8%; symptoms and complications recovery;
discontinuing medication after 3 months or more.
Prominent Effect: FPG <7.8 mmol/L (140 mg/dl), HbA1c <8%; symptoms
improved and complications reduced.
Effective: FPG reduced 3.33 mmol/L (60 mg/dl), HbA1c <9%.
Ineffective: No evidence of symptom improvement and reduction of criteria
established for diabetes mellitus.
Results
After 4 months of treatment and monitoring, of patients with Type 1 diabetes, 84
(6.80%) demonstrated clinical recovery, 106 (8.58%) prominent effect, 144
(11.65%) some effect, and 902 (72.98%) no effect. Over the same period, 1794
(19.12%) patients with Type 2 diabetes demonstrated clinical recovery, 2346
(25.01%) prominent effect, 3835 (40.88%) some effect, and 1407 (15.00%) no
effect. Overall totals were 1,878 (17.69%), 2,452 (23.09%), 3,979 (37.47%) and
2,309 (21.75%) respectively.2
Effect of Yu Xiao San 8805 on the Treatment of Hyperglycemia Using a
Streptozotocin-Induced Insulin Resistant Diabetic Rat Model
In a placebo controlled experiment on the effect of Yu Xiao San 8805 on the
treatment of hyperglycemia using a streptozotocin-induced insulin resistant
diabetic rat model with the Medical School of Stanford University in the United
States3 in 1994, about 100 rats were introduced and were divided into three
groups - placebo, Yu Xiao San 8805, and a western drug "Metformin". Dr. Ida Chen,
director of General Clinical Research Core Laboratory and senior research
scientist of Stanford University School of Medicine, stated that ?Yu Xiao San
8805 has shown statistically significant effect on the increase in triglycerides
(TG) in these streptozotocin-induced insulin resistant diabetic rats.
Specifically, plasma TG concentration tends to increase in diabetic rats (and in
diabetic patients); both Metformin and Yu Xiao San 8805 appeared to have a
"controlling" effect - i.e. "they alleviated the increment of TG occurring in
these rats."4
Pancreas Islet Cells Stimulation by Euonymus alatus
Scientists from Japan have tested that Euonymus alata sieb has a
blood sugar lowering action. The administration from the sodium oxalacetate, the
effective component of Euonymus alata sieb brought about lowering of the blood
sugar level in normal and alloxan diabetic animals. The same drug was given to
diabetic patients, and it found effective in all of 10 of Type I and in 6 of 11
of Type II diabetics. It was also found that long-term administration of sodium
oxalacetate induced hyperplasia and proliferation of the islet cells of the
pancreas in rats, but no mentionable changes were found in other organs.5
The findings suggest that the active component of Euonymus alata sieb stimulates
the islet cells, regulates the abnormal metabolic process, and enhances the
secretion of insulin, and thereby controls the diabetic condition.6
Hypoglycemic Effects of Yu Xiao San 8805?s Other Selected
Ingredients
Yu Xiao San 8805 is composed of the following ingredients:
Euonymus alatus, Cortex Lycii Radicis, Arctium Lappa L., Platycodon Grandiflorum,
Litchi Chinensis, Curcuma longa, Panax quinquefolium L.
Euonymus Alatus
In an experiment with normal mice and Alloxan induced diabetic
mice, Euonymus Alatus showed hypoglycemic effects. The fasting serum glucose
level in diabetic mice was reduced significantly, but similar effect on fasting
serum glucose level was not produced in normal mice.7
Cortex Lycii Radicis
It is reported that soluble molecules of Cortex Lycii Radicis
had hypoglycemic effects on rats.8
Arctium Lappa L.
Animal data: Streptozotocin-induced diabetic mice given burdock
experienced
aggravation of hyperglycemia .9 However, studies in non-diabetic rats indicate
some
hypoglycemic effects .10
Human data: Reports from the 1930's stated that as the amount of burdock
in the diet of
diabetics increased, blood sugar levels and insulin requirements decreased .11
Platycodon Grandiflorum
The effect of Platycodon grandiflorum on the improvement of insulin resistance
and lipid profile was investigated in lean (Fa/-) and obese (fa/fa) Zucker rats,
a model for noninsulin dependent diabetes mellitus. Dietary Platycodon
grandiflorum feeding for 4 weeks resulted in a significant decrease in the
concentration of plasma triglyceride in both lean and obese Zucker rats.
Furthermore, dietary Platycodon grandiflorum markedly decreased both plasma
cholesterol and fasting plasma insulin levels, and significantly decreased the
postprandial glucose level at 30 min during oral glucose tolerance test in obese
Zucker rats. Although there was no statistical significance, the crude glucose
transporter 4 protein level of obese rats fed Platycodon grandiflorum tended to
increase when compared with that of obese control rats. Therefore, the present
results suggested that Platycodon grandiflorum may be useful in prevention and
improvement of metabolic disorders characterized by hyperinsulinemia states such
as noninsulin dependent diabetes mellitus, syndrome X, and coronary artery
disease.12
Curcuma longa (Turmeric)
In a research study of the effect of turmeric(Curcuma longa) and
its active principle, curcumin, on diabetes mellitus in an Alloxan induced
diabetic rat model. Administration of turmeric or curcumin to diabetic rats
reduced the blood sugar, Hb and glycosylated hemoglobin levels significantly.
Turmeric and curcumin supplementation also reduced the oxidative stress
encountered by the diabetic rats. This was demonstrated by the lower levels of
TBARS (thiobarbituric acid reactive substances), which may have been due to the
decreased influx of glucose into the polyol pathway leading to an increased
NADPH/NADP ratio and elevated activity of the potent antioxdiant enzyme GPx.
Moreover, the activity of SDH (sorbitol dehydrogenase), which catalyzes the
conversion of sorbitol to fructose, was lowered significantly on treatment with
turmeric or curcumin.13
Panax quinquefolium L. (American Ginseng)
In a double blind, randomized, placebo-controlled preliminary
short-term clinical study to examine the effects of postprandial glycemia in
humans, American ginseng (Panax qinquefolius L) Ginseng attenuated postprandial
glycemia in both diabetic and nondiabetic subjects. No differences were found in
postprandial glycemia between placebo and ginseng when administered together
with the glucose challenge to non-diabetic subjects. When ginseng was taken 40
minutes before the glucose challenge, significant reductions were observed
(P<.05). In subjects with type 2 diabetes mellitus, the same was true whether
capsules were taken before or together with the glucose challenge (P<.05).
Reductions in area under the glycemic curve were 18%+/-31% for nondiabetic
subjects and 19+/-22% and 22+/-17% for subjects with type 2 diabetes mellitus
administered before or together with the glucose challenge, respectively.14
Conclusion
Yu Xiao San 8805, composed of material medica of Traditional
Chinese Medicine has been used since 1988 as a Traditional Chinese Medicine for
Type I and Type II diabetic patients in China Beijing Chaoyang District Red
Cross Hospital (presently Beijing Anyuan Hospital) as well as other state
hospitals in China. Clinical study in 1992 of 10618 cases, and an animal study
in 1994 suggested that Yu Xiao San 8805 lowered blood sugar levels and had a
controlling effect on triglycerides (TG) levels, respectively. Studies of
ingredients of Yu Xiao San 8805 also suggested various hypoglycemic effects.
Further studies are needed to investigate the mechanisms of Yu Xiao San 8805's
functions in human body.
References
1 Choate, Clinton, J., L.Ac., MTOM, Dip.NBAO, "Modern Medicine and Traditional
Chinese Medicine - Diabetes Mellitus", Journal of Chinese Medicine, No. 60, May.
1999.
2 Ibid.
3 Preliminary results were given for this animal experiment.
4 Chen, Ida, Ph.D. In a letter to Beijing Health Bureau regarding the effect of
Yu Xiao San 8805 on the treatment of hyperglycemia using a Streptozotocin-induced
insulin resistant diabetic rat model, dated June 25, 1994.
5 Chemistry Abstract. 70:18809a: Antidiabetic effect of sodium oxalacetate.
Yoshikawa, Kiyohiko. Iwaki Kyoritsu Hosp., Iwaki, Japan. Tohoku Journal of
Experimental Medicine (1968), 96 127-41.
6 Ibid. Pg. 136.
7 Lang SM, Zhu DN, Yu BY, Zhao JL, Wang QJ, Hypoglycemic Effects of Extracts and
Constituents from Euonymus Alatus. Journal of China Pharmaceutical University,
2003, 34(2): 128-131
8 Zhou J, Qiao W, Zhang Y, Zhao B, Screening on effective composition of Cortex
Lycii Radicis (CLR) in alloxan diabetic mice. Journal of Chinese Traditional
Patent Medicine, September, 2002.
9 Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ. Glycaemic effects of
traditional European plant treatments for diabetes. Studies in normal and
streptozotocin diabetic mice. Diabetes Research 1989; 10:69-73.
10 Lapinina L, Sisoeva T. Investigation of some plants to determine their sugar
lowering action. Farmatsevt 1964; 19:52-8.
11 Silver AA, Krantz JC, Jr. The Effect of the Ingestion of Burdock Root on
Normal and Diabetic Individuals;a Preliminary Report. Annals of Internal
Medicine 1931; 5:274-84.
12 Kim K, Seo E, Lee Y, Lee T, Cho Y, Ezaki O, Kim C., Effect of Dietary
Platycodon Grandiflorum on the Improvement of Insulin Resistance in Obese Zucker
Rats, The Journal of Nutritional Biochemistry, Volume 11, Issue 9 , September
2000, Pages 420-424
13 Arun N, Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in
diabetic albino rats. Plant Foods Hum Nutr. 2002 Winter;57(1):41-52.
14 Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z,
Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia
in nondiabetic subjects and subjects with type 2 diabetes mellitus. Archives of
Internal Medicine, 2000 Apr 10;160(7):1009-13.
Other Supplements:
Cortiloss,
Cortislim,
Enzyte,
Ogoplex,
5 HTP,
Chitosan,
Stacker 2,
Stacker 3,
Stamina,
Zantrex
|
|
